Split History
ATXI split history picture
Avenue Therapeutics (ATXI) has 2 splits in our ATXI split history database. The first split for ATXI took place on September 23, 2022. This was a 1 for 15 reverse split, meaning for each 15 shares of ATXI owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split. ATXI's second split took place on April 26, 2024. This was a 1 for 75 reverse split, meaning for each 75 shares of ATXI owned pre-split, the shareholder now owned 1 share. For example, a 66.6666666666667 share position pre-split, became a 0.888888888888889 share position following the split.

When a company such as Avenue Therapeutics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the ATXI split history from start to finish, an original position size of 1000 shares would have turned into 0.888888888888889 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Avenue Therapeutics shares, starting with a $10,000 purchase of ATXI, presented on a split-history-adjusted basis factoring in the complete ATXI split history. ATXI split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/29/2017
End date: 06/21/2024
Start price/share: $8,865.00
End price/share: $3.36
Dividends collected/share: $0.00
Total return: -99.96%
Average Annual Total Return: -67.63%
Starting investment: $10,000.00
Ending investment: $3.79
Years: 6.98
Avenue Therapeutics is a pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. Co.'s product candidates include AJ201 for the treatment of spinal and bulbar muscular atrophy, intravenous Tramadol for the treatment of post-operative acute pain, and BAER-101 for the treatment of epilepsy and panic disorders. According to our ATXI split history records, Avenue Therapeutics has had 2 splits.
Date Ratio
09/23/20221 for 15
04/26/20241 for 75
ATXI is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

AVEO Split History
AVGR Split History
AVXL Split History
AXDX Split History
AYTU Split History
AZN Split History
AZRX Split History
BAX Split History
BCR Split History
BDMS Split History

Also explore: ATXI shares outstanding history

Email EnvelopeFree ATXI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Crown Electrokinetics Corp. (CRKN)
Medalist Diversified REIT, Inc. (MDRR)
Medalist Diversified REIT, Inc. (MDRR)
Qilian International Holding Group Limited (QLI)
Bluejay Diagnostics, Inc. (BJDX)
Atara Biotherapeutics, Inc. (ATRA)
GRI Bio, Inc. (GRI)
Williams-Sonoma, Inc. (WSM)
Workhorse Group Inc. (WKHS)
Virgin Galactic Holdings, Inc. (SPCE)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

ATXI Insider Buying

ATXI Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.